During the past decade, Cedars-Sinai Comprehensive Transplant Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cedars-Sinai Comprehensive Transplant Center" #1 sponsor was "Pfizer" with 2 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "European Foundation for Study of Chronic Liver Failure" with 1 trials sponsored and "Sequana Medical N.V." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Cedars-Sinai Comprehensive Transplant Center" are "Liver Cirrhosis" (2 trials), "Acute-On-Chronic Liver Failure" (1 trials), "Ascites" (1 trials), "Chronic Hepatitis B" (1 trials) and "Focal Segmental Glomerulosclerosis (FSGS)" (1 trials). Many other conditions were trialed in "Cedars-Sinai Comprehensive Transplant Center" in a lesser frequency.

Most popular intervention types in "Cedars-Sinai Comprehensive Transplant Center" are "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Alfapump" (1 trials), "CC-90001" (1 trials), "Observational Protocol" (1 trials) and "Other anti-HBV medication" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cedars-Sinai Comprehensive Transplant Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cedars-Sinai Comprehensive Transplant Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cedars-Sinai Comprehensive Transplant Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cedars-Sinai Comprehensive Transplant Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".